awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q35975387-219A0548-18C9-4F61-AFCC-23BB6829654B
Q35975387-219A0548-18C9-4F61-AFCC-23BB6829654B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35975387-219A0548-18C9-4F61-AFCC-23BB6829654B
The tipping point for combination therapy: cancer vaccines with radiation, chemotherapy, or targeted small molecule inhibitors
P2860
Q35975387-219A0548-18C9-4F61-AFCC-23BB6829654B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35975387-219A0548-18C9-4F61-AFCC-23BB6829654B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
10a9413a781a884512c73e3495f420efd5f6e7d7
P2860
Orally administered lenalidomide (CC-5013) is anti-angiogenic in vivo and inhibits endothelial cell migration and Akt phosphorylation in vitro.